Literature DB >> 20947551

Infections in systemic lupus erythematosus.

S V Navarra1, M S N Leynes.   

Abstract

Infections are an important cause of morbidity and mortality in systemic lupus erythematosus (SLE). Survival rates for SLE patients in developing countries are comparatively lower than those reported in industrialized countries, with early death from infection and active disease. In addition to the role of immunosuppressive agents in enhancing susceptibility to infection, infectious agents are also known to trigger lupus disease expression and activity. The endemicity of certain infections like tuberculosis further poses a special health issue in developing countries.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20947551     DOI: 10.1177/0961203310374486

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  22 in total

Review 1.  Can procalcitonin be used to distinguish between disease flare and infection in patients with systemic lupus erythematosus: a systematic literature review.

Authors:  Ilaria Serio; Laurent Arnaud; Alexis Mathian; Pierre Hausfater; Zahir Amoura
Journal:  Clin Rheumatol       Date:  2014-07-27       Impact factor: 2.980

2.  Aspergillus-associated cerebral aneurysm successfully treated by endovascular and surgical intervention with voriconazole in lupus nephritis patient.

Authors:  Yong Chul Kim; Hajeong Lee; Han Hee Ryu; Seung Hoon Beom; Yaewon Yang; Suhnggwon Kim; Ho Jun Chin
Journal:  J Korean Med Sci       Date:  2012-02-23       Impact factor: 2.153

3.  Retrospective analysis on the impact of tuberculosis on patients with systemic lupus erythematosus (SLE).

Authors:  Chang-Ran Zhang; Yuan-Yuan Niu; Jian-Cong Lin; Wen-Hui Wu; Ming Li; Jian-Feng Li
Journal:  Rheumatol Int       Date:  2012-01-03       Impact factor: 2.631

4.  Usefulness of neutrophil-to-lymphocyte ratio as a biomarker for diagnosing infections in patients with systemic lupus erythematosus.

Authors:  Hyoun-Ah Kim; Ju-Yang Jung; Chang-Hee Suh
Journal:  Clin Rheumatol       Date:  2017-08-24       Impact factor: 2.980

5.  Periodontitis treatment improves systemic lupus erythematosus response to immunosuppressive therapy.

Authors:  Cristiana Fabbri; Ricardo Fuller; Eloisa Bonfá; Lissiane K N Guedes; Paulo Sergio R D'Alleva; Eduardo F Borba
Journal:  Clin Rheumatol       Date:  2014-01-11       Impact factor: 2.980

6.  Unchanging premature mortality trends in systemic lupus erythematosus: a general population-based study (1999-2014).

Authors:  April M Jorge; Na Lu; Yuqing Zhang; Sharan K Rai; Hyon K Choi
Journal:  Rheumatology (Oxford)       Date:  2018-02-01       Impact factor: 7.580

Review 7.  [Changes in mortality and morbidity in systemic lupus erythematosus].

Authors:  G Chehab; R Fischer-Betz; M Schneider
Journal:  Z Rheumatol       Date:  2011-08       Impact factor: 1.372

8.  The risk of tuberculosis in SLE patients from an Asian tertiary hospital.

Authors:  Yong Yang; Julian Thumboo; Ban Hock Tan; Thuan Tong Tan; Chern Hui Jeffrey Fong; Han Seong Ng; Kok Yong Fong
Journal:  Rheumatol Int       Date:  2017-03-12       Impact factor: 2.631

9.  Levels of serum procalcitonin and C-reactive protein for evaluating pulmonary bacterial infection in patients with lupus erythematosus.

Authors:  Jing Gao; Lei Zhang; Xin Zhang; Shi-Long Zhao; Sheng-Yun Liu; Li-Hua Xing
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

10.  The Chinese version of the SLEQOL is a reliable assessment of health-related quality of life in Han Chinese patients with systemic lupus erythematosus.

Authors:  Hai-Zhi Jiang; Zhi-Guo Lin; Hong-Juan Li; Qing -Du; Wei -Tian; Shu-Ya Wang; Shang-Qi Guan; Yi-Fang Mei
Journal:  Clin Rheumatol       Date:  2017-11-22       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.